Evidence map›Paper›PMID 37755104›Full record

ArticleMarine drugs2023

Two New Components from an Association of Marine Sponges

Buyng Su Hwang, Sangbum Lee, Eun Ju Jeong, Jung-Rae Rho

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Buyng Su HwangBio-Resource Industrialization Center, Nakdonggang National Institute of Biological Resources, Sangju 37242, Republic of Korea.ORCID 0000-0002-6774-7294
Sangbum LeeDepartment of Oceanography, Kunsan National University, Kunsan 54150, Republic of Korea.
Eun Ju JeongDepartment of GreenBio Science, Gyeongsang National University, Jinju 52725, Republic of Korea.
Jung-Rae RhoDepartment of Oceanography, Kunsan National University, Kunsan 54150, Republic of Korea.ORCID 0000-0001-6443-632X
Kunsan National University · KRGyeongsang National University · KRNational Institute of Biological Resources · KR

Funding

Korea Institute of Marine Science & Technology (KIMST) RS-2023-00256330
6 · The paper itself

Abstract

Benign prostatic hyperplasia (BPH), characterized by the enlargement of the prostate gland and subsequent lower urinary tract symptoms, poses a significant health concern for aging men with increasing prevalence. Extensive efforts encompassing in vitro and in vivo models are underway to identify novel and effective agents for the management and treatment of BPH. Research endeavors are primarily channeled toward assessing the potential of compounds to inhibit cell proliferation, curb inflammation, and display anti-androgenic activity. Notably, through screening aimed at inhibiting 5-alpha reductase type 2 (5αR2) in human prostatic cells, two acyl compounds (

Indexed as

5-alpha Reductase InhibitorsPoriferaProstatic HyperplasiaAnimalsBiomarkersCell ProliferationHumansMaleProstate5-alpha Reductase InhibitorsBiomarkers(2S, 3S)-capreomycidine5-alpha reductase type 2benign prostatic hyperplasia (BPH)ECD comparisonJBCAmarine spongetramiprosate

Identifiers

PMID37755104
PMCPMC10532625
OpenAlexW4386781641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.